Cardiovascular risk in persons at risk of developing rheumatoid arthritis

被引:10
作者
van Boheemen, Laurette [1 ]
van Beers-Tas, Marian H. [1 ]
Kroese, Johanna M. [2 ,3 ,4 ,5 ]
van de Stadt, Lotte A. [1 ]
van Schaardenburg, Dirkjan [6 ]
Nurmohamed, Michael T. [1 ,7 ]
机构
[1] Reade, Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Orofacial Pain & Dysfunct, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Periodontol, Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Prevent Dent, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Amsterdam, Netherlands
[6] Univ Amsterdam, Med Ctr, AMC, Dept Rheumatol, Amsterdam, Netherlands
[7] Univ Amsterdam, Med Ctr, VUmc, Dept Rheumatol, Amsterdam, Netherlands
来源
PLOS ONE | 2020年 / 15卷 / 08期
关键词
INTIMA-MEDIA THICKNESS; RESTING HEART-RATE; BLOOD-DONORS; LIPID-LEVELS; INFLAMMATION; DISEASE; MORTALITY; DYSLIPIDEMIA; POPULATION; ARTHRALGIA;
D O I
10.1371/journal.pone.0237072
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group. Methods In a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline. Results Preclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls. Conclusion Our results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Autonomic function and rheumatoid arthritis-A systematic review
    Adlan, Ahmed M.
    Lip, Gregory Y. H.
    Paton, Julian F. R.
    Kitas, George D.
    Fisher, James P.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2014, 44 (03) : 283 - 304
  • [2] Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis
    Alemao, Evo
    Cawston, Helene
    Bourhis, Francois
    Al, Maiwenn
    Rutten-van Molken, Maureen
    Liao, Katherine P.
    Solomon, Daniel H.
    [J]. RHEUMATOLOGY, 2017, 56 (05) : 777 - 786
  • [3] [Anonymous], 2017, BMJ BRIT MED J, DOI DOI https://doi.org/10.1136/bmj.j
  • [4] Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus
    Aydemir, M.
    Yazisiz, V.
    Basarici, I.
    Avci, A. B.
    Erbasan, F.
    Belgi, A.
    Terzioglu, E.
    [J]. LUPUS, 2010, 19 (03) : 255 - 261
  • [5] Inflammation, Adiposity, and Atherogenic Dyslipidemia in Rheumatoid Arthritis: Is There a Paradoxical Relationship?
    Bag-Ozbek, Ayse
    Giles, Jon T.
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2015, 15 (02) : 1 - 10
  • [6] How early is the atherosclerotic risk in rheumatoid arthritis?
    Bartoloni, Elena
    Alunno, Alessia
    Bistoni, Onelia
    Gerli, Roberto
    [J]. AUTOIMMUNITY REVIEWS, 2010, 9 (10) : 701 - 707
  • [7] Perceived and actual risk of cardiovascular disease in patients with rheumatoid arthritis in Korea: A cross-sectional study
    Boo, Sunjoo
    Froelicher, Erika S.
    Yun, Ju-Hui
    Kim, Ye-Won
    Jung, Ju-Yang
    Suh, Chang-Hee
    [J]. MEDICINE, 2016, 95 (40)
  • [8] Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study
    Bos, W. H.
    Wolbink, G. J.
    Boers, M.
    Tijhuis, G. J.
    de Vries, N.
    van der Horst-Bruinsma, I. E.
    Tak, P. P.
    van de Stadt, R. J.
    van der Laken, C. J.
    Dijkmans, B. A. C.
    van Schaardenburg, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (03) : 490 - 494
  • [9] Antibodies to citrullinated peptides and risk of coronary heart disease
    Cambridge, Geraldine
    Acharya, Jayshree
    Cooper, Jackie A.
    Edwards, Jonathan C.
    Humphries, Steve E.
    [J]. ATHEROSCLEROSIS, 2013, 228 (01) : 243 - 246
  • [10] Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
    Choy, E.
    Sattar, N.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (04) : 460 - 469